Edition:
United States

Benitec Biopharma Ltd (BLT.AX)

BLT.AX on Australia Stock Exchange

0.13AUD
20 Jul 2017
Change (% chg)

-- (--)
Prev Close
$0.13
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
146,747
52-wk High
$0.28
52-wk Low
$0.09

BLT.AX

Chart for BLT.AX

About

Benitec Biopharma Limited is a biotechnology company. The Company is engaged in progressing programs through the clinic; the commercialization of its Intellectual Property (IP); development of its therapeutic pipeline and pre-clinical programs, and funding, and protecting and building the IP estate. Its In-house product... (more)
No analyst recommendations are available for BLT.AX.

Overall

Beta: 2.00
Market Cap(Mil.): $26.67
Shares Outstanding(Mil.): 205.14
Dividend: --
Yield (%): --

Financials

  BLT.AX Industry Sector
P/E (TTM): -- 212.65 15.78
EPS (TTM): -- -- --
ROI: -- -7.61 -8.29
ROE: -- -9.04 -7.91

BRIEF-Benitec Biopharma says files for stock shelf offering of upto $20 mln

* Benitec Biopharma says files for stock shelf offering of upto $20 million - sec filing Source text (http://bit.ly/2rIk5RV) Further company coverage:

Jun 01 2017

BRIEF-Benitec Biopharma says key pre-clinical data on muscular dystrophy published in nature communications

* Benitec Biopharma Ltd - key pre-clinical data on oculopharyngeal muscular dystrophy (opmd) published in nature communications

Apr 04 2017

BRIEF-Benitec Biopharma initiates work on two oncology pipeline programs

* Initiated work on two new oncology pipeline programs after executing a research collaboration agreement with Nant Capital Llc Source text for Eikon: Further company coverage:

Jan 29 2017

Earnings vs. Estimates